CDC42 and coronary artery disorder: CDC42 was reduced in DCB-treated SV-CAD patients compared to HCs [median (IQR): 501.0 (361.0-806.0) vs. 1144.5 (739.0-1675.5) pg/mL] (P < 0.001) (Fig. 1A).